Earnings Feed
Start Free
ZIOPHARM ONCOLOGY INC·4

Jan 5, 2:47 PM ET

FRAGIN GARY S 4

4 · ZIOPHARM ONCOLOGY INC · Filed Jan 5, 2010

Insider Transaction Report

Form 4
Period: 2009-12-31
ZIOPHARM ONCOLOGY INCZIOP
FRAGIN GARY S
Director
Transactions
  • Award

    Common Stock, $.001 par value

    2009-12-31+7,500→ 52,500 total
  • Award

    Stock Option (right to buy)

    2009-12-31+7,500→ 7,500 total
    Exercise: $2.85Exp: 2019-12-31→ Common Stock, $.001 par value (7,500 underlying)
Holdings

  • Director Stock Option (right to buy)

    Exercise: $5.01From: 2006-04-26Exp: 2016-04-26→ Common Stock (15,000 underlying)
    15,000

  • Stock Option (right to buy)

    Exercise: $2.73Exp: 2017-12-12→ Common Stock (20,000 underlying)
    20,000

  • Director Stock Option (right to buy)

    Exercise: $4.31Exp: 2014-12-22→ Common Stock, $.001 par value (15,029 underlying)
    15,029

  • Stock Option (right to buy)

    Exercise: $4.85Exp: 2017-06-18→ Common Stock (15,000 underlying)
    15,000
Footnotes (7)
  • [F1]7,515 shares vest on 12/22/05 and 7,514 shares vest on 12/22/06.
  • [F2]5,000 shares vest on each of 12/13/07, 12/13/08 and 12/13/09.
  • [F3]5,000 shares vest on each of 6/18/08, 6/18/09 and 6/18/10.
  • [F4]6,667 shares vest on each of 12/12/08 and 12/12/09; 6,666 shares vest on 12/12/10.
  • [F5]5,000 shares vest on each of 12/31/2009, 6/30/2010 and 12/31/2010.
  • [F6]Grant of restricted stock; restrictions lapse in 2 equal annual installments beginning on the first anniversary of the date of grant.
  • [F7]3,750 shares vest on each of 12/31/2011 and 12/31/2012.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -